Join to View Full Profile
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center1650 Orleans St. CRB1Baltimore, MD 21287
Phone+1 267-334-5333
Fax+1 410-847-2063
Dr. Nakajima is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Johns Hopkins UniversityFellowship, Medical Oncology, 2018 - 2020
University of Pittsburgh School of MedicineClass of 2015
Vanderbilt University Medical CenterResidency, Internal Medicine
Certifications & Licensure
MD State Medical License 2019 - 2025
DC State Medical License 2021 - 2024
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 1 citations[F]F-AraG Uptake in Vertebral Bone Marrow May Predict Survival in Patients with Non-Small Cell Lung Cancer Treated with Anti-PD-(L)1 Immunotherapy.Jelena Levi, Millie Das, Minal S Vasanawala, Deepti Behl, Martin Pomper
Journal of Nuclear Medicine. 2024-12-03 - 2 citationsTumor Size Is Not Everything: Advancing Radiomics as a Precision Medicine Biomarker in Oncology Drug Development and Clinical Care. A Report of a Multidisciplinary Wor...Erica C Nakajima, Amber Simpson, Jan Bogaerts, Elisabeth G E de Vries, Richard Do
JCO Precision Oncology. 2024-04-01 - 130 citationsFDA Approval Summary: Sotorasib for KRAS G12C-Mutated Metastatic NSCLC.Erica C Nakajima, Nicole Drezner, Xiaoxue Li, Pallavi S Mishra-Kalyani, Yajun Liu
Clinical Cancer Research. 2022-04-14
Press Mentions
FDA Analyses Provide Insights into First-Line Treatment for Advanced NSCLCJune 5th, 2022
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
